Polydopamine surface-modified nanocarriers for improved anticancer activity: Current progress and future prospects
From its inception, plenty of anticancer agents and gene therapies have been developed to account for cancer treatment. Despite this, the effectiveness of these therapies is flawed by toxic effects and failure to efficiently reach the target site. In this shade, novel drug delivery systems with adva...
Main Authors: | Sandip M. Honmane, Manoj S. Charde, Sachin S. Salunkhe, Prafulla B. Choudhari, Sopan N. Nangare |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | OpenNano |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352952022000226 |
Similar Items
-
Polydopamine-Based Nanocarriers for Photosensitizer Delivery
by: Yuxuan Xiong, et al.
Published: (2019-07-01) -
Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro
by: Mengwen Guo, et al.
Published: (2023-04-01) -
Polydopamine Nanosystems in Drug Delivery: Effect of Size, Morphology, and Surface Charge
by: Arianna Menichetti, et al.
Published: (2024-02-01) -
Recent Development of Polydopamine Anti-Bacterial Nanomaterials
by: Zhengwei Xu, et al.
Published: (2022-06-01) -
Nanoparticles modified by polydopamine: Working as “drug” carriers
by: Anting Jin, et al.
Published: (2020-09-01)